Posted on

scientific hemp oil

RSHO™ is natural, full spectrum CBD oil extracted from hemp plants grown in Northern Europe. The farming co-op that grows our hemp relies upon centuries of traditional hemp cultivation practices to allow us to create a complete CBD oil from healthy, contaminant-free hemp. Our non-GMO hemp is cultivated without the use of any herbicides, pesticides, or chemical fertilizers to ensure a reliable and safe end product. Strict EU regulations ensure an impeccably pure hemp oil before it comes to us in the United States. RSHO™ passes all federal requirements for open importation into the U.S.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

RSHO™ stands out because it is the first approved medical cannabis product in three Latin American countries: Brazil, Mexico, and Paraguay, as well as the U.S. territory of Puerto Rico.

for the latest updates from Medical Marijuana, Inc.

Like all our CBD hemp oil products, RSHO™ is available in all 50 states and in over 40 countries worldwide. However, RSHO™ stands out because it is the first approved medical cannabis product in three Latin American countries: Brazil, Mexico, and Paraguay, as well as the U.S. territory of Puerto Rico.

We continuously scrutinize our processes to meet all regulations and lead all CBD products in quality. RSHO™ is the first CBD hemp oil to be inspected and Triple Lab Tested® at ISO/IEC 17025:2005 accredited food safety laboratories, guaranteeing a high quality product.

RSHO Advocate Penny Howard to Share Story on How Her Fight to Save Daughter Harper Helped Legalize New Markets and Change Lives in Latin America Medical Marijuana, Inc.  (OTC: MJNA) today announced that at the 3rd Annual Cannabis World Congress and Business Expo (CWCBE) in New York on June 17, the Company’s CEO Dr. Stuart Titus will speak on how the world stands to benefit both nutritionally and therapeutically from Cannabidiol (CBD) – a nutritious, non-psychoactive substance derived from industrial hemp. Medical Marijuana, Inc. 

HempMeds® to Educate Thousands of Global Healthcare Professionals Attending the World Congress on Anti-Aging Medicine on Rapidly Emerging Hemp Cannabidiol (CBD) Industry Medical Marijuana, Inc.  (OTC: MJNA) announced today that its subsidiary HempMeds®  is exhibiting at the 24th annual American Academy of Anti-Aging Medicine World Congress (A4M), with the Company’s extensive portfolio of retail-ready cannabis products featured at the Venetian/Palazzo Hotel in Las Vegas from Dec. 9-11. HempMeds® 

Hemp Industry Pioneer Looks to Expand Rapidly Growing Sales Team For New Markets Including Latin America Medical Marijuana, Inc.’s  (OTC: MJNA) management team announced today that the Company is launching a new hiring drive for sales professionals as it continues rapid expansion in the United States and international markets including Latin America. “The world is waking up to the vast untapped potential of cannabinoid (CBD) hemp oil and our flagship product, Real Scientific Hemp Oil™  (RSHO™ ),


Mexico Political News Site Animal Politico Also Highlights Continued Demand for Medical Marijuana in Mexico Medical Marijuana, Inc.  (OTC: MJNA) announced today that it applauds the Mexican Senate for its unanimous approval of legalizing medicinal marijuana in Mexico. The Senate’s vote supports Mexican President Enrique Pena Nieto’s proposal to reform Mexico’s General Health Law and the country’s Federal Penal Code to relax laws against marijuana, including medical use. In addition, national news outlets in Mexico continue to detail the increasing demand for

Consumers Looking for Zero THC Version of Real Scientific Hemp Oil (RSHO™) Products Now Have Solution From First-Ever Approved Company Medical Marijuana, Inc.  (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Real Scientific Hemp Oil-X™ (RSHO-X™)  product line is now being imported into Brazil through the company’s subsidiary, HempMeds Brasil™ . The RSHO-X™ 

RSHO and RSHO-X Garner Global Headlines as Part of Cannabis World Congress and Business Expo in New York Medical Marijuana, Inc.  (OTC: MJNA) is pleased to announce today that its hemp oil products and CEO Dr. Stuart Titus were featured in global news coverage including TV interviews and news articles as part of coverage from the Cannabis World Congress and Business Expo (CWCBE), which was held at the Javits Center in New York City from June 16-17. Dr. Titus spoke at the CWCBE about how the world stands to benefit both nutritionally and therapeutically from

Massive Coverage Across Latin America After Government of Paraguay Grants First-Ever Import Permit for Real Scientific Hemp Oil™ (RSHO™) Medical Marijuana, Inc.  (OTC Pink: MJNA) announced today that the Associated Press and Paraguay’s top television news channel Telefuturo covered the historic news of the government of Paraguay granting its first-ever import permit for Real Scientific Hemp Oil ™ (RSHO™) as a prescription medication for refractory epilepsy. The Associated Press article 

Potential Competing Interests: The authors report no competing interests.

Please note that Internet Explorer version 8.x is not supported as of January 1, 2016. Please refer to this support page for more information.

Add to Mendeley

Citing articles

Cannabidiol (CBD) oils are low tetrahydrocannabinol products derived from Cannabis sativa that have become very popular over the past few years. Patients report relief for a variety of conditions, particularly pain, without the intoxicating adverse effects of medical marijuana. In June 2018, the first CBD-based drug, Epidiolex, was approved by the US Food and Drug Administration for treatment of rare, severe epilepsy, further putting the spotlight on CBD and hemp oils. There is a growing body of preclinical and clinical evidence to support use of CBD oils for many conditions, suggesting its potential role as another option for treating challenging chronic pain or opioid addiction. Care must be taken when directing patients toward CBD products because there is little regulation, and studies have found inaccurate labeling of CBD and tetrahydrocannabinol quantities. This article provides an overview of the scientific work on cannabinoids, CBD, and hemp oil and the distinction between marijuana, hemp, and the different components of CBD and hemp oil products. We summarize the current legal status of CBD and hemp oils in the United States and provide a guide to identifying higher-quality products so that clinicians can advise their patients on the safest and most evidence-based formulations. This review is based on a PubMed search using the terms CBD, cannabidiol, hemp oil, and medical marijuana. Articles were screened for relevance, and those with the most up-to-date information were selected for inclusion.

We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies .